Skip to main content
. 2020 Nov 23:1–16. doi: 10.1080/07391102.2020.1850360

Figure 8.

Figure 8.

Drug perturbations on A-549 cell lines that reverse the gene signatures observed in COVID-19. Perturbations of F-1566-0341 shown in pink ellipses. Perturbation of Digoxin in blue; Perturbation of Proscillaridin in green and Perturbation of Linifanib in yellow.